🔎 Trials Near Me

መነሻ › ስቴቶቲክ የጉበት በሽታ › Texas › Austin

በAustin፣ TX ለስቴቶቲክ የጉበት በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች

ለስቴቶቲክ የጉበት በሽታ የሚደረጉ 13 ጥናቶች በAustin እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07701993

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • American Research Corporation, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • American Research Corporation, Austin
  • Pinnacle Clinical Research - Austin, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • IMA Clinical Research Austin, Austin
  • American Research Corporation, Austin
  • Pinnacle Clinical Research, Austin
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Akero Clinical Study Site, Austin
  • Akero Clinical Study Site, Austin
  • Akero Clinical Study Site, Austin
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Pinnacle Clinical Research, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT07288138

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06419374

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • GSK Investigational Site, Austin
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁላይ 2026 · NCT06920043

በሌሎች ከተሞች ለስቴቶቲክ የጉበት በሽታ የሚደረጉ ጥናቶች

በAustin ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።